Upcoming Webinar: Overview of the CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule

Updated Webinar Access Information:
April 16 - CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule Webinar

Due to overwhelming interest in the upcoming CMS Interoperability Standards and Prior Authorization for Drugs proposed rule webinar, we have updated the webinar access details to accommodate additional attendees.

The webinar taking place on Thursday, April 16 at 12:00 PM EDT will now be held as a Town Hall. Registration is no longer required, and the access link has changed.

Please use the updated link to join the webinar: Join Webinar

This session will provide an overview of the proposed rule (CMS-0062-P), including key provisions related to electronic prior authorization, interoperability standards, and improvements to the prior authorization process.

We appreciate the strong interest and look forward to your participation.

If you have any questions, please contact CMSInteroperability@cms.hhs.gov.

Get the latest news about CMS' Burden Reduction Efforts by visiting our Subscriber's Preferences page.

You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS).

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com.

This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS).

This email was sent to NPrm5pk4s@niepodam.pl using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244

Updated Webinar Access Information:April 16 - CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule Webinar

Updated Webinar Access Information:
April 16 - CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule Webinar